← All stocks

Relay Therapeutics, Inc.

RLAY Net selling

CIK 0001812364 #1471 in the set updated 17 Sep 2026

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$118.88M

$2.48M on a plan · $0.00 straight out of an exercise

Sold at will

$116.40M

1 of 6 sales

Net

−$118.88M

−$116.40M against sales at will

By person

6 insiders · 6 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

SVF Pauling (Cayman) Ltd entity

10% owner

—

$116.40M (1)

−$116.40M

21,904,963

10.00%

$414.88M

−21.5%

Patel Sanjiv

President and CEO

—

$1.89M (2) scheduled

−$1.89M

1,605,951

0.7328%

$30.42M

−31.0%

Catinazzo Thomas

Chief Financial Officer

—

$335.56K (1) scheduled

−$335.56K

122,851

0.0561%

$2.33M

−54.6%

Bergstrom Donald A

President, R&D

—

$161.81K (1) scheduled

−$161.81K

399,130

0.1821%

$7.56M

−10.1%

Rahmer Peter

See remarks

—

$90.30K (1) scheduled

−$90.30K

223,657

0.1021%

$4.24M

−34.8%

Adams Brian

Chief Legal Officer

—

371,472

0.1695%

$7.04M

+14.7%

Individual transactions

Insider

Date

Role

Action

Price

Amount

Patel Sanjiv

8 Sep 2026

President and CEO

Sold on a plan

48,199

$18.94

$912.89K

Catinazzo Thomas

8 Sep 2026

Chief Financial Officer

Sold on a plan

17,717

$18.94

$335.56K

Bergstrom Donald A

8 Sep 2026

President, R&D

Sold on a plan

8,530

$18.97

$161.81K

Rahmer Peter

26 Aug 2026

See remarks

Sold on a plan

4,508

$20.03

$90.30K

SVF Pauling (Cayman) Ltd

25 Aug 2026

10% owner

Sell indirect

6,000,000

$19.40

$116.40M

Patel Sanjiv

17 Aug 2026

President and CEO

Sold on a plan

48,199

$20.33

$979.89K

What was left out

Form 4 filings counted 7

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 1

Sales on a Rule 10b5-1 plan 5

Sales straight out of an exercise 0

Sales at will 1

Transactions with no price 0

Shares from compensation/vesting 0

History held since 20 Jul 2020